Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advancing combination treatment with glycyrrhizin and boswellic acids for hospitalized patients with moderate COVID-19 infection: a randomized clinical trial
Adel A. Gomaa, Hamdy Saad Mohamed, Rasha B. Abd-ellatief, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 2, pp. 477-486
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

SARS-CoV-2 Drug Resistance and Therapeutic Approaches
Sania Batool, Santosh Chokkakula, Ju Hwan Jeong, et al.
Heliyon (2025) Vol. 11, Iss. 2, pp. e41980-e41980
Open Access | Times Cited: 3
Traditional herbs against COVID-19: back to old weapons to combat the new pandemic
Hayder M. Al‐kuraishy, Omnia Momtaz Al-Fakhrany, Engy Elekhnawy, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 50
A Review of the Antiviral Activities of Glycyrrhizic Acid, Glycyrrhetinic Acid and Glycyrrhetinic Acid Monoglucuronide
Jiawei Zuo, Tao Meng, Yuanyuan Wang, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 641-641
Open Access | Times Cited: 31
Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics
Yash Gupta, Oleksandr V. Savytskyi, Matt Coban, et al.
Molecular Aspects of Medicine (2022) Vol. 91, pp. 101151-101151
Open Access | Times Cited: 30
Plants as Biofactories for Therapeutic Proteins and Antiviral Compounds to Combat COVID-19
Corbin England, Jonathan TrejoMartinez, Paula PerezSanchez, et al.
Life (2023) Vol. 13, Iss. 3, pp. 617-617
Open Access | Times Cited: 15
Exploring autophagy in treating SARS-CoV-2 spike protein-related pathology
Matthew Halma, Paul E. Marik, Yusuf M. Saleeby
Endocrine and Metabolic Science (2024) Vol. 14, pp. 100163-100163
Open Access | Times Cited: 3
Glycyrrhizin Enhances the Proliferation of Diabetic Bone Marrow-derived Mesenchymal Stem Cells: A Potential Therapeutic Agent in Endodontic Surgery
Mohamed Ahmed Gomaa, Yousry Mahmoud Elhawary, Amany E. Badr
The Journal of Contemporary Dental Practice (2023) Vol. 24, Iss. 7, pp. 494-499
Open Access | Times Cited: 9
Targeting neutrophils extracellular traps, a promising anti-thrombotic therapy for natural products from traditional Chinese herbal medicine
Lei Wei, Xiao Li, Shanze Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117310-117310
Open Access | Times Cited: 2
Phytochemicals for mitigating the COVID-19 crisis: evidence from pre-clinical and clinical studies
A. M. Das, Swarnali Khan, Syamal Roy, et al.
(2023), pp. 336-376
Open Access | Times Cited: 6
Review from host and guest approach to new frontiers nutraceuticals in the era of COVID-19
Matteo Micucci, Silvia Gioacchini, Melissa Baggieri, et al.
Future Foods (2024) Vol. 9, pp. 100303-100303
Open Access | Times Cited: 1
Formulation and in vitro characterization of nanoemulsions containing remdesivir or licorice extract: A potential subcutaneous injection for coronavirus treatment
Al Zahraa G. Al Ashmawy, Gehan F. Balata
Colloids and Surfaces B Biointerfaces (2023) Vol. 234, pp. 113703-113703
Closed Access | Times Cited: 4
Glycyrrhizin and boswellic acids, the golden nutraceuticals: multitargeting for treatment of mild–moderate COVID-19 and prevention of post-COVID cognitive impairment
Adel A. Gomaa, Yasmin A. Abdel-Wadood, Mohamed Gomaa
Inflammopharmacology (2022) Vol. 30, Iss. 6, pp. 1977-1992
Open Access | Times Cited: 7
An outlook on the target‐based molecular mechanism of phytoconstituents as immunomodulators
Gazala Noor, Badruddeen Badruddeen, Juber Akhtar, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 11, pp. 5058-5079
Open Access | Times Cited: 3
Effect of anti-inflammatory drugs on the storm of inflammatory factors in respiratory tract infection caused by SARS-CoV-2: an updated meta-analysis
Zhiping Qin, Yongbiao Li, Wenjing Sun, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 3
Prospects of Novel and Repurposed Immunomodulatory Drugs against Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19 Disease
Smruti Sudha Nayak, Akshayata Naidu, Sajitha Lulu, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 4, pp. 664-664
Open Access | Times Cited: 2
Plant-Derived Antioxidants for Management of COVID-19: A Comprehensive Review of Molecular Mechanisms.
Tahmineh Mokhtari, Maryam Azizi, Fatemeh Sheikhbahaei, et al.
PubMed (2023) Vol. 22, Iss. 1, pp. 27-39
Closed Access | Times Cited: 2
Dietary Indian frankincense (Boswellia serrata) ameliorates murine allergic asthma through modulation of the gut microbiome
Cassandra Suther, Liv Devon, Lauren Daddi, et al.
Journal of Functional Foods (2022) Vol. 97, pp. 105249-105249
Open Access | Times Cited: 4
Can the golden nutraceutical frankincense combat COVID‐19?
Hidayat Hussain
Future Postharvest and Food (2024) Vol. 1, Iss. 1, pp. 161-165
Open Access
Neuro-protective Effect of Acetyl-11-keto-β-boswellic Acid in a Rat Model of Scopolamine-induced Cholinergic Dysfunction
Amir Hossein Assaran, Mahmoud Hosseini, Matin Shirazinia, et al.
Current Pharmaceutical Design (2024) Vol. 30, Iss. 2, pp. 140-150
Closed Access
ANTIVIRAL POTENTIAL OF HERBAL MEDICINE IN FIGHTING COVID-19 PANDEMIC, RE-INVESTIGATION OF HERBAL MONOGRAPHS
Mayssaloune Ali Kanso, ZEINA AHMAD OMEICHE, Mohamad Ali Hijazi, et al.
International Journal of Pharmacy and Pharmaceutical Sciences (2024), pp. 18-25
Open Access
Saponins as potential inhibitors targeting SARS-CoV-2
Nurten Abaci Kaplan, İlkay Erdoğan Orhan
Elsevier eBooks (2024), pp. 131-150
Closed Access
Terpenes and terpenoids as potential inhibitors targeting SARS-CoV-2
Ramazan Ceylan, Leyla Paşayeva, Serdar Korpayev, et al.
Elsevier eBooks (2024), pp. 211-240
Closed Access
Molecular Targets Underlying the Neuroprotective Effects of Boswellic Acid: A Systematic Review
Faezeh Khaafi, Behjat Javadi
Mini-Reviews in Medicinal Chemistry (2023) Vol. 23, Iss. 19, pp. 1912-1925
Closed Access | Times Cited: 1
Natural compounds from medicinal plants against COVID-19
Anton S. Kolodnitsky, Н. С. Ионов, I. V. Gravel, et al.
(2023), pp. 253-275
Open Access | Times Cited: 1
Efficacy and safety of licorice (Glycyrrhiza glabra) in moderately ill patients with COVID-19: a randomized controlled trial
Ali Ameri, Mehdi Farashahinejad, Parivash Davoodian, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 6, pp. 3037-3045
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top